Robert Feltgen

Executive Partner

Salt Creek Capital

Joined: 2023

Office Phone:

(415) 238-4876


  Pro - Try 1 Week Free
 

    and access,

  •     80K PE/M&A Contacts
  •     +
  •     4.6K PE Firms
  •     3.6K M&A Advisors
  •     199K Transactions
  •     202K Companies

  •     Market Services
  •     Build Lists
  •     Research Sectors
  •     Uncover Opportunities

Bio

Bob joined Salt Creek Capital as an Executive Partner in 2023, bringing more than 30 years of experience of global sales, marketing, and general management in manufacturing, business services, biotechnology, medical device, and the pharmaceutical industries. He has built high performing sales and marketing organizations across both large public and private companies. Bob has also co-founded NERx Biosciences, a pre-clinical oncology company focused on the next generation of targeted therapeutics for the treatment of cancer. Prior to joining Salt Creek Capital Bob served as the Senior Vice President at Magnetrol International Incorporated, a global manufacturer of process instrumentation utilized across multiple industries including chemical, power, oil & gas, and pharma. He restructured the direct sales organization and upgraded the global channel partners which resulted in consistent double-digit revenue growth and a 3x +increase in the enterprise value. Working closely with the owner, Bob was integral in the highly successful sale of Magnetrol to a large public company in 2021. Prior to Magnetrol, Bob was the Director of Vitreoretinal Products in North America for Bausch & Lomb, a leading global health organization. Prior to that, Bob held various roles at Merck & Co., Kos Pharmaceuticals and Smithkline Beecham. Bob holds a bachelor’s degree in business from Purdue University.

Education